LSX - partnering for Life Science eXecutives reposted this
🌟 Planning for Cell & Gene Therapy Commercialisation Webinar! Join Us on October 18th, 2023 at 3 PM BMT/4 PM CET/10 AM EST 🌟 🧬 Mark your calendars for an enlightening webinar where we dive deep into the intricate world of Cell & Gene Therapy commercialisation and discuss ways to make these groundbreaking treatments more accessible to all. 🗓️ Date: Wednesday, October 18th, 2023 🕒 Time: 3:00 PM BMT 🚀 Planning for Cell & Gene Therapy Commercialization 🚀 🔗 Register here: https://lnkd.in/eErnRw4m If you've ever wondered about the challenges of bringing cell & gene therapies to market, you're not alone. It's a complex journey filled with trials, scaling manufacturing capabilities, navigating market access, and orchestrating successful launches. All of this can drive up costs, making it a lengthy and expensive road for patients seeking treatment. 🌟 Our panel of industry experts include... 🔹 Matthew Booth, SVP Global Therapy Lead, ApotheCom, an Inizio Company 🔹 Ben Beckley, President, Evoke Mind+Matter 🔹 Dean McAlister, EVP, Inizio 🔹 Greg Christianson, Principal, Nuvera Life Science Consulting 🔹 Rita Johnson-Greene, MBA, COO, Alliance for Regenerative Medicine #CellGeneTherapy #HealthcareInnovation #Webinar #IndustryExperts #HealthcareRevolution #FreeEvent
Ben Beckley
11mo
Looking forward to it.
Thanks to Dean and the Inizio team for inviting me to participate in this panel. What a great discussion! I am grateful to have been able to share my experience launching three of the eight rare disease gene therapy products on the market today.